These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17723123)

  • 1. Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients.
    Paniccia R; Antonucci E; Gori AM; Marcucci R; Giglioli C; Antoniucci D; Gensini GF; Abbate R; Prisco D
    J Thromb Haemost; 2007 Sep; 5(9):1839-47. PubMed ID: 17723123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Light transmittance aggregometry induced by different concentrations of adenosine diphosphate to monitor clopidogrel therapy: a methodological study.
    Paniccia R; Antonucci E; Maggini N; Miranda M; Romano E; Gori AM; Marcucci R; Prisco D; Abbate R
    Ther Drug Monit; 2011 Feb; 33(1):94-8. PubMed ID: 21192314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel.
    Bouman HJ; Parlak E; van Werkum JW; Breet NJ; ten Cate H; Hackeng CM; ten Berg JM; Taubert D
    J Thromb Haemost; 2010 Mar; 8(3):482-8. PubMed ID: 20040042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to antiplatelet therapy is independent of endogenous thrombin generation potential.
    Gremmel T; Panzer S; Steiner S; Seidinger D; Koppensteiner R; Pabinger I; Kopp CW; Ay C
    Thromb Res; 2013 Jul; 132(1):e24-30. PubMed ID: 23623170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    J Thromb Haemost; 2010 Jan; 8(1):37-42. PubMed ID: 19818001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of different methods to evaluate the effect of aspirin on platelet function in high-risk patients with ischemic heart disease receiving dual antiplatelet treatment.
    Paniccia R; Antonucci E; Gori AM; Marcucci R; Poli S; Romano E; Valente S; Giglioli C; Fedi S; Gensini GF; Abbate R; Prisco D
    Am J Clin Pathol; 2007 Jul; 128(1):143-9. PubMed ID: 17580282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients.
    Paniccia R; Antonucci E; Maggini N; Miranda M; Gori AM; Marcucci R; Giusti B; Balzi D; Prisco D; Abbate R
    Thromb Haemost; 2010 Aug; 104(2):287-92. PubMed ID: 20458439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of the INNOVANCE PFA P2Y system to detect clopidogrel-induced ADP receptor blockade in preangiocath individuals.
    McGlasson DL; Shah AD; Fritsma GA
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):583-7. PubMed ID: 21799401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-parameter assessment of platelet inhibition and its stability during aspirin and clopidogrel therapy.
    Timur AA; Murugesan G; Zhang L; Barnard J; Bhatt DL; Kottke-Marchant K
    Thromb Res; 2014 Jul; 134(1):96-104. PubMed ID: 24852729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new INNOVANCE® PFA P2Y cartridge is sensitive to the detection of the P2Y₁₂ receptor inhibition.
    Koessler J; Kobsar AL; Rajkovic MS; Schafer A; Flierl U; Pfoertsch S; Bauersachs J; Steigerwald U; Rechner AR; Walter U
    Platelets; 2011; 22(1):20-7. PubMed ID: 20873965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematocrit alters VerifyNow P2Y12 assay results independently of intrinsic platelet reactivity and clopidogrel responsiveness.
    Kakouros N; Kickler TS; Laws KM; Rade JJ
    J Thromb Haemost; 2013 Oct; 11(10):1814-22. PubMed ID: 24118870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the role of the new INNOVANCE PFA P2Y test cartridge in detection of clopidogrel resistance.
    Tsantes A; Ikonomidis I; Papadakis I; Kottaridi C; Tsante A; Kalamara E; Kardoulaki A; Kopterides P; Kapsimali V; Karakitsos P; Lekakis J; Travlou A
    Platelets; 2012; 23(6):481-9. PubMed ID: 22646492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High on-treatment platelet reactivity in patients with ischemic cerebrovascular disease: assessment of prevalence and stability over time using four platelet function tests.
    Jover E; Rodríguez JM; Bernal A; Arroyo AB; Iniesta JA; Guiú IS; Martínez C; Vicente V; Lozano ML; Rivera J
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):604-11. PubMed ID: 24717421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the proton pump inhibitors and CYP2C19*2 polymorphism on platelet response to clopidogrel as assessed by four platelet function assays.
    Tsantes AE; Ikonomidis I; Papadakis I; Bonovas S; Gialeraki A; Kottaridi C; Kyriakou E; Kokori S; Douramani P; Kopterides P; Karakitsos P; Lekakis J; Kapsimali V
    Thromb Res; 2013 Aug; 132(2):e105-11. PubMed ID: 23830212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between the vasodilator-stimulated phosphoprotein phosphorylation assay and light transmittance aggregometry in East Asian patients after high-dose clopidogrel loading.
    Kim IS; Jeong YH; Tantry US; Park Y; Lee DH; Bliden KP; Koh JS; Park JR; Jang JS; Hwang SJ; Koh EH; Kwak CH; Hwang JY; Kim S; Gurbel PA
    Am Heart J; 2013 Jul; 166(1):95-103. PubMed ID: 23816027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between light transmission aggregometry, VerifyNow P2Y12, and VASP-P platelet reactivity assays following percutaneous coronary intervention.
    Gaglia MA; Torguson R; Pakala R; Xue Z; Sardi G; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    J Interv Cardiol; 2011 Dec; 24(6):529-34. PubMed ID: 21919956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    Thromb Haemost; 2009 Feb; 101(2):333-9. PubMed ID: 19190818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influencing factors for clopidogrel-mediated platelet inhibition are assay-dependent.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    Thromb Res; 2011 Oct; 128(4):352-7. PubMed ID: 21621250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of platelet sensitization to ADP following discontinuation of clopidogrel therapy in patients with stable coronary artery disease.
    Lordkipanidzé M; Diodati JG; Schampaert E; Palisaitis DA; Pharand C
    Platelets; 2015; 26(6):545-51. PubMed ID: 25167467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.